Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vardenafil.

Jay M Young1

  • 1South Orange County Medical Research Center, Laguna Woods, California 92653, USA. jyoung@southcountyurology.com

Expert Opinion on Investigational Drugs
|October 22, 2002
PubMed
Summary
This summary is machine-generated.

Vardenafil hydrochloride, a phosphodiesterase Type 5 inhibitor, effectively treats erectile dysfunction by enhancing penile blood flow. Clinical trials confirm its safety and efficacy for men seeking improved erectile function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.

Cancer prevention research (Philadelphia, Pa.)·2012
Same author

Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.

The Journal of urology·2007
Same author

Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial.

The Journal of urology·2007
Same author

Sustained efficacy and safety of vardenafil for treatment of erectile dysfunction: a randomized, double-blind, placebo-controlled study.

Mayo Clinic proceedings·2005
Same author

Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial.

Journal of andrology·2005
Same author

Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups.

Urology·2003
Same journal

Advancements in longevity pharmacology research - are we finally seeing clinical progression?

Expert opinion on investigational drugs·2026
Same journal

Consideration of the use of nalbuphine in idiopathic pulmonary fibrosis-associated cough: to cough or not to cough so much?

Expert opinion on investigational drugs·2026
Same journal

Investigational new drug TAP-1502 beginning clinical study for seborrheic dermatitis.

Expert opinion on investigational drugs·2026
Same journal

Cannabinoid use in adults with sickle cell disease: therapeutic development and clinical insights.

Expert opinion on investigational drugs·2026
Same journal

Odronextamab: a bispecific antibody for follicular lymphoma.

Expert opinion on investigational drugs·2026
Same journal

Evaluating the investigational drug landscape for <i>ESR1</i>-mutated, estrogen receptor-positive, HER2-negative metastatic breast cancer.

Expert opinion on investigational drugs·2026
See all related articles

Area of Science:

  • Pharmacology
  • Urology

Background:

  • Erectile dysfunction (ED) affects numerous men.
  • Existing therapies have limitations.
  • Need for effective and safe oral ED treatments.

Purpose of the Study:

  • To review the development of vardenafil hydrochloride.
  • To summarize clinical effectiveness and safety data.
  • To highlight vardenafil's potential as an ED therapy.

Main Methods:

  • In vitro assays.
  • Pre-clinical studies.
  • Phase III clinical trials in diverse patient populations.

Main Results:

  • Vardenafil hydrochloride demonstrated potent and selective phosphodiesterase Type 5 inhibition.

Related Experiment Videos

  • Clinical trials confirmed significant improvements in achieving and sustaining erections.
  • Favorable safety profile observed across broad and special populations.

    • Conclusions:

    • Vardenafil hydrochloride is an effective and safe oral treatment for erectile dysfunction.
    • The compound represents a potential advance over existing ED therapies.
    • Anticipated availability in 2003 for ED patients.